Wellstar Atlanta Medical Center is a hospital in Atlanta, Georgia operated by Wellstar Health System. It has 460 beds and over 700 physicians. The hospital is a Level I Trauma Center, and an Advanced Primary Stroke Center. It houses a Neurointensive Care Unit and a Level III Neonatal ICU.

There are 460 beds in Atlanta Medical Center.

During the past decade, Atlanta Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Medical Center" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Conatus Pharmaceuticals Inc." with 1 trials sponsored, "Cook Group Incorporated" with 1 trials sponsored and "Crux Biomedical" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Medical Center" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Nonin Medical" with 1 trials as a collaborator, "United States Department of Defense" with 1 trials as a collaborator, "University of Florida" with 1 trials as a collaborator and "University of North Carolina, Chapel Hill" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Medical Center" are "Hepatitis C" (5 trials), "Pulmonary Embolism" (2 trials), "Acute Compartment Syndrome" (1 trials), "Anterior Tibial Compartment Syndrome" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Atlanta Medical Center" in a lesser frequency.

Most popular intervention types in "Atlanta Medical Center" are "Drug" (7 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ribavirin" (3 trials), "Daclatasvir" (2 trials), "Placebo" (2 trials), "CTS-1027" (1 trials) and "Elafibranor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Medical Center" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Atlanta Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Atlanta Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".